Dura Pharmaceuticals Inc.

Alexza Pharmaceuticals Inc. put another piece of the puzzle in place for the launch of the inhalable antipsychotic Adasuve with an announcement May 8 that it has partnered the drug with Teva Pha

Relentless consolidation, cost-cutting, coordination of patient care, and re-allocation of risk trends currently underway in the U.S. healthcare system provide unprecedented opportunities for investor

Ellen Foster Licking On Friday, March 7 Eli Lilly & Co. confirmed rumors that had been swirling for much of the day: the company had terminated development of its Phase III inhaled insulin, AIR

Born of a leveraged buy-out, MedPointe is subject to financial restraints that demand focus on earnings. Beyond competing with far bigger pharma marketers, management's key challenge remains bringing